Aeolus Pharmaceuticals Stock Price, News & Analysis (OTCMKTS:AOLS)

$0.10 0.00 (0.00 %)
(As of 11/18/2017 04:00 PM ET)
Previous Close$0.10
Today's Range$0.08 - $0.10
52-Week Range$0.05 - $0.25
Volume23,425 shs
Average Volume11,447 shs
Market Capitalization$15.21 million
P/E RatioN/A
Dividend YieldN/A
Beta1.47

About Aeolus Pharmaceuticals (OTCMKTS:AOLS)

Aeolus Pharmaceuticals logoAeolus Pharmaceuticals, Inc. is a biopharmaceutical company. The Company focuses on developing a platform of compounds for use in biodefense, fibrosis, oncology, infectious disease and diseases of the central nervous system. As of September 30, 2016, the Company's platform consisted of approximately 180 compounds licensed from the University of Colorado (UC), Duke University (Duke) and National Jewish Health (NJH). The Company's lead compound is AEOL 10150, which is being developed as a medical countermeasure (MCM) against the pulmonary sub-syndrome of acute radiation syndrome (Pulmonary Acute Radiation Syndrome or Lung-ARS) and the delayed effects of acute radiation exposure (DEARE). Its other product is AEOL 11114 and AEOL 20415. AEOL 10150 is indicated for the treatment of radiation oncology and idiopathic pulmonary fibrosis. AEOL 11114 is indicated for the treatment of Parkinson's disease and epilepsy. AEOL 20415 is an orally-available, anti-infective compound.


Industry, Sector and Symbol:
  • Industry: Drug Manufacturers - Other
  • Sub-Industry: N/A
  • Sector: Medical
  • Symbol: OTCMKTS:AOLS
  • CUSIP: N/A
  • Web: www.aeoluspharma.com
Debt:
  • Current Ratio: 1.31%
  • Quick Ratio: 1.31%
Sales & Book Value:
  • Annual Sales: $2.08 million
  • Price / Sales: 7.31
  • Book Value: $0.02 per share
  • Price / Book: 5.00
Profitability:
  • Trailing EPS: ($0.04)
  • Net Income: ($3,550,000.00)
  • Net Margins: -531.00%
  • Return on Equity: -246.63%
  • Return on Assets: -175.14%
Misc:
  • Employees: 4
  • Outstanding Shares: 152,090,000
 

Frequently Asked Questions for Aeolus Pharmaceuticals (OTCMKTS:AOLS)

What is Aeolus Pharmaceuticals' stock symbol?

Aeolus Pharmaceuticals trades on the OTCMKTS under the ticker symbol "AOLS."

How were Aeolus Pharmaceuticals' earnings last quarter?

Aeolus Pharmaceuticals Inc. (OTCMKTS:AOLS) announced its quarterly earnings data on Monday, August, 14th. The biopharmaceutical company reported ($0.01) EPS for the quarter. The biopharmaceutical company earned $0.01 million during the quarter. Aeolus Pharmaceuticals had a negative net margin of 531.00% and a negative return on equity of 246.63%. View Aeolus Pharmaceuticals' Earnings History.

When will Aeolus Pharmaceuticals make its next earnings announcement?

Aeolus Pharmaceuticals is scheduled to release their next quarterly earnings announcement on Wednesday, December, 20th 2017. View Earnings Estimates for Aeolus Pharmaceuticals.

Who are some of Aeolus Pharmaceuticals' key competitors?

Who are Aeolus Pharmaceuticals' key executives?

Aeolus Pharmaceuticals' management team includes the folowing people:

  • David C. Cavalier, Chairman of the Board, Interim Chief Financial Officer (Age 45)
  • John L. McManus, President, Chief Executive Officer (Age 50)
  • John M. Clerici, Independent Director (Age 44)
  • John M. Farah Jr., Ph.D., Independent Director (Age 62)
  • Mitchell D. Kaye J.D., Independent Director (Age 46)
  • Amit Kumar Ph.D., Independent Director (Age 53)
  • Chris A. Rallis, Independent Director (Age 61)

How do I buy Aeolus Pharmaceuticals stock?

Shares of Aeolus Pharmaceuticals can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Aeolus Pharmaceuticals' stock price today?

One share of Aeolus Pharmaceuticals stock can currently be purchased for approximately $0.10.

How big of a company is Aeolus Pharmaceuticals?

Aeolus Pharmaceuticals has a market capitalization of $15.21 million and generates $2.08 million in revenue each year. The biopharmaceutical company earns ($3,550,000.00) in net income (profit) each year or ($0.04) on an earnings per share basis. Aeolus Pharmaceuticals employs 4 workers across the globe.

How can I contact Aeolus Pharmaceuticals?

Aeolus Pharmaceuticals' mailing address is 26361 CROWN VALLEY PARKWAY SUITE 150, MISSION VIEJO CA, 92691. The biopharmaceutical company can be reached via phone at 949-481-9825 or via email at [email protected]


MarketBeat Community Rating for Aeolus Pharmaceuticals (OTCMKTS AOLS)

Community Ranking:  1.9 out of 5 (star)
Outperform Votes:  19 (Vote Outperform)
Underperform Votes:  31 (Vote Underperform)
Total Votes:  50
MarketBeat's community ratings are surveys of what our community members think about Aeolus Pharmaceuticals and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Analysts' Consensus Rating for Aeolus Pharmaceuticals (OTCMKTS:AOLS)

  (How are Consensus Ratings Calculated?)
Ratings Breakdown: 0 Sell Ratings, 0 Hold Ratings, 0 Buy Ratings, 0 Strong Buy RatingsNo ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Analysts' Consensus Price Target: N/A

Consensus Price Target History for Aeolus Pharmaceuticals (OTCMKTS:AOLS)

Price Target History for Aeolus Pharmaceuticals (OTCMKTS:AOLS)

Analysts' Ratings History for Aeolus Pharmaceuticals (OTCMKTS:AOLS)

Show:
No equities research coverage for this company has been tracked by MarketBeat.com

Earnings

Earnings History and Estimates Chart for Aeolus Pharmaceuticals (OTCMKTS:AOLS)

Earnings by Quarter for Aeolus Pharmaceuticals (OTCMKTS:AOLS)

Earnings History by Quarter for Aeolus Pharmaceuticals (OTCMKTS AOLS)

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
12/20/2017        
8/14/2017Q3 2017($0.01)$0.01 millionViewN/AView Earnings Details
5/15/2017Q2 2017($0.01)$0.13 millionViewN/AView Earnings Details
2/17/2017Q1 2017($0.01)$0.08 millionViewN/AView Earnings Details
8/17/2015Q3 2015($0.01)$0.06 millionViewN/AView Earnings Details
2/13/2015Q1 2015($0.01)$0.93 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Aeolus Pharmaceuticals (OTCMKTS:AOLS)

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Aeolus Pharmaceuticals (OTCMKTS:AOLS)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for Aeolus Pharmaceuticals (OTCMKTS AOLS)

Insider Ownership Percentage: 66.60%
Insider Trades by Quarter for Aeolus Pharmaceuticals (OTCMKTS:AOLS)

Insider Trades by Quarter for Aeolus Pharmaceuticals (OTCMKTS AOLS)

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
3/6/2013John L McmanusCEOBuy10,000$0.35$3,500.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Aeolus Pharmaceuticals (OTCMKTS AOLS)

Source:

Social Media

Financials

Chart

Aeolus Pharmaceuticals (OTCMKTS AOLS) Chart for Sunday, November, 19, 2017
Loading chart…

This page was last updated on 11/19/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.